Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05284708 · ClinicalTrials.gov registry record · NA
Atalante USAbility
A NA study, sponsored by Wandercraft.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05284708 is a NA study that has completed, run by Wandercraft. The registered enrollment target is 20 participants.
The verdict
NCT05284708, a NA study, has completed, sponsored by Wandercraft.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The "USAbility" study - Human Factor Validation Testing of the Atalante exoskeleton aims at demonstrating that Atalante can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.
Interventions
- DEVICE Atalante
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2022-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05284708
The ClinicalTrials.gov registry entry for NCT05284708 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wandercraft, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atalante is the first listed.
NCT05284708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05284708 about?
NCT05284708 is a clinical study titled "Atalante USAbility". The "USAbility" study - Human Factor Validation Testing of the Atalante exoskeleton aims at demonstrating that Atalante can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.
What is the current status of trial NCT05284708?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-11-29. Estimated completion is 2022-01-10.
What interventions are being tested in trial NCT05284708?
The interventions under investigation include: Atalante (DEVICE).
Who is sponsoring clinical trial NCT05284708?
This trial is sponsored by Wandercraft, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.